BBVA
ABBV icon

Banco Bilbao Vizcaya Argentaria’s AbbVie ABBV Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$73.1M Sell
336,329
-284
-0.1% -$63K 0.51% 29
2025
Q4 		$77M Sell
336,613
-20,090
-6% -$4.58M 0.54% 29
2025
Q3 		$82.5M Sell
356,703
-22,214
-6% -$4.52M 0.63% 26
2025
Q2 		$70.3M Buy
378,917
+2,514
+0.7% +$467K 0.64% 26
2025
Q1 		$78.9M Buy
376,403
+17,470
+5% +$3.4M 0.79% 20
2024
Q4 		$64M Sell
358,933
-21,773
-6% -$4M 0.67% 20
2024
Q3 		$75.1M Buy
380,706
+21,719
+6% +$4.05M 0.75% 20
2024
Q2 		$61.6M Buy
358,987
+4,594
+1% +$761K 0.65% 22
2024
Q1 		$64.2M Sell
354,393
-22,484
-6% -$3.87M 0.74% 24
2023
Q4 		$58.4M Sell
376,877
-828
-0.2% -$121K 0.69% 26
2023
Q3 		$56M Buy
377,705
+5,516
+1% +$810K 0.75% 18
2023
Q2 		$50.2M Buy
372,189
+17,879
+5% +$2.62M 0.65% 23
2023
Q1 		$56.4M Buy
354,310
+11,589
+3% +$1.77M 0.7% 24
2022
Q4 		$55.4M Sell
342,721
-8,073
-2% -$1.24M 0.81% 19
2022
Q3 		$47M Buy
350,794
+16,936
+5% +$2.43M 0.76% 21
2022
Q2 		$51.1M Buy
333,858
+10,156
+3% +$1.55M 0.77% 21
2022
Q1 		$52.8M Buy
323,702
+130,751
+68% +$19M 0.71% 25
2021
Q4 		$26.2M Buy
192,951
+41,055
+27% +$4.85M 0.35% 55
2021
Q3 		$16.5M Sell
151,896
-16,153
-10% -$1.85M 0.26% 73
2021
Q2 		$18.9M Buy
168,049
+59,897
+55% +$6.75M 0.34% 54
2021
Q1 		$11.7M Buy
108,152
+22,893
+27% +$2.45M 0.23% 86
2020
Q4 		$9.13M Sell
85,259
-1,899
-2% -$182K 0.21% 92
2020
Q3 		$7.63M Sell
87,158
-26,066
-23% -$2.45M 0.22% 82
2020
Q2 		$11.1M Buy
113,224
+8,910
+9% +$784K 0.36% 53
2020
Q1 		$7.95M Buy
104,314
+43,530
+72% +$3.71M 0.28% 69
2019
Q4 		$5.38M Buy
+60,784
New +$5.05M 0.17% 130

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's ABBV Position: Q1 2026 in Review

Banco Bilbao Vizcaya Argentaria reduced its AbbVie (ABBV) stake by 0.08% in Q1 2026, selling an estimated $63K and leaving 336,329 shares worth $73.1M. The position accounts for 0.51% of the portfolio, ranked #29.

Banco Bilbao Vizcaya Argentaria first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $82.5M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Banco Bilbao Vizcaya Argentaria held 336,329 shares of AbbVie worth $73.1M as of Q1 2026.
  • Banco Bilbao Vizcaya Argentaria sold 284 AbbVie shares in Q1 2026, an estimated $63K.
  • AbbVie made up 0.51% of Banco Bilbao Vizcaya Argentaria's portfolio in Q1 2026, its #29 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • Banco Bilbao Vizcaya Argentaria's AbbVie position peaked at $82.5M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q1 2026, filed 14 May 2026.